OncoNexus
@Onco_Nexus
Oncology Nexus is a real-world oncology insights platform led by multidisciplinary physicians delivering multimedia to an audience of oncology specialists.
579 Following 164 Followers
How are oncologists choosing first-line therapy for advanced HCC in an increasingly crowded treatment landscape?
Learn more with @TheGutOncLab as Dr. Mark Yarchoan (@MarkYarchoan) joins Dr. Nicholas Hornstein (@GIMedOnc), Dr. Timothy Brown, MD MSCE (@TimothyJBrownMD), and Dr. Udhayvir Singh Grewal MD (@UGrewalMD), to break down the frontline treatment framework for advanced hepatocellular carcinoma, including how patient and disease characteristics influence the choice between today’s leading immunotherapy-based combinations.
Watch the full episode on OncoNexus:
Show more
How has systemic therapy changed the role of TACE in intermediate-stage HCC?
In this episode from @TheGutOncLab , Dr. Mark Yarchoan (@MarkYarchoan) joins Drs. Nicholas Hornstein (@GIMedOnc), Timothy Brown, MD MSCE (@TimothyJBrownMD), & Udhay Singh Grewal, MD (@UGrewalMD) to discuss the evolving role of TACE alongside systemic therapy in HCC and what recent combination data may mean for treatment selection and sequencing.
As immunotherapy-based regimens move earlier in the treatment landscape, the group explores where TACE still fits, which patients may benefit most from a combined approach, and how practice could continue to evolve.
Watch the full discussion on Oncology Nexus:
Show more
What should patients (and the physicians guiding them) know when considering a clinical trial?
In this episode of @TheGutOncLab, Dr. Nicholas Hornstein (@GIMedOnc), Dr. Timothy Brown, MD MSCE (@TimothyJBrownMD), & Dr. Udhayvir Singh Grewal, MD (@UGrewalMD) unpack how to evaluate trial design, treatment phase, control arms, potential benefit, and the realities behind survival endpoints.
A practical conversation for clinicians counseling patients and for patients trying to better understand their options:
Show more
